GSK’s ex-head of vaccines says its blockbuster jab for a flu-like virus that spreads in the autumn and winter is too ...

With respiratory viruses ramping up as we look to cooler days, vaccination season has arrived again. The newest vaccine to protect against Covid-19 has hit pharmacies, and Allegheny County residents ...

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. (NASDAQ: MRNA ) between January 18, 2023 and June 25, 2024, both dates inclusive (the "Class ...

Moderna, Inc. and Cenra Healthcare, the sales and marketing arm of Cenra Inc., today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA ...

GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...

Forecasts suggest respiratory infections will be similar to last year's season. Vaccination rates will be a factor in the ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Due to the remarkable success of the Research Topic 'High-Impact Respiratory RNA Virus Diseases' and the rapidly evolving subject area, we are pleased to launch Volume II for this topic. The threat ...

Two Montgomery County commissioners rolled up their sleeves and got vaccinated, receiving their flu and COVID-19 shots during ...